(2R,3R,4R,5S)-6-(Dimethylamino)hexane-1,2,3,4,5-pentol, commonly known as N-Methyl-D-glucamine (MEG), is a derivative of D-glucose where the primary hydroxyl group is replaced by a dimethylamino group. It is a white, crystalline solid that is highly soluble in water and exhibits basic properties due to the tertiary amine functionality. N-Methyl-D-glucamine is a versatile compound with significant applications in the pharmaceutical and life sciences industries. Its primary use is as a key counterion for the formation of pharmaceutically acceptable salts of acidic drugs, particularly those containing carboxylic acid or sulfonic acid groups. These salts often improve the solubility, stability, and bioavailability of the active pharmaceutical ingredient (API). It is also employed as a chiral auxiliary in asymmetric synthesis and as a ligand for metal complexation. Furthermore, it serves as a precursor for the synthesis of various surfactants and functional materials. Beyond its role in drug formulation, MEG is utilized in biochemical research as a component of buffers and as a reagent for the modification of carbohydrates and other biomolecules. Its safety profile is generally favorable, but standard laboratory precautions for handling fine chemicals should be observed.